Navigation Links
Patient Safety Technologies Reports Third Quarter 2008 Results
Date:11/24/2008

rket differentiated products and commercialize its product pipeline. Patient Safety Technologies cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: the growth rate of the sponge market, uncertainty of success in developing new products or products currently in SurgiCount's pipeline, the ability to develop and expand its business in the United States, unanticipated expenses or liabilities or other adverse events affecting cash flow or SurgiCount's ability to successfully control its costs or achieve profitability uncertainty of additional funding, SurgiCount's ability to compete with other competing products and with emerging new technologies, product liability exposure, patent infringement claims and claims related to SurgiCount's intellectual property. Please refer to the risk detailed from time to time in Patients Safety Technologies SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Patient Safety Technologies, Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise, unless required by law.



               PATIENT SAFETY TECHNOLOGIES, INC. AND SUBSIDIARY
              Condensed Consolidated Balance Sheets (Unaudited)
                       (In thousands, except par value)

                                                    September 30, December 31,
                                                        2008          2007
                             Assets

    Current assets:
        Cash and cash equivalents                      $1,038         $405
        Accounts receivable                               325           72
        Inventories 
'/>"/>
SOURCE Patient Safety Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. The First Treatment Specifically Approved for Huntingtons Disease Patients is Now Available in the United States
2. Life-Saving Airman, Leukemia Patient Meet for First Time
3. New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
4. Final Rule Issued for Patient Safety Organizations
5. Heart patients are often not treated in accordance with guidelines
6. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
7. Initial Survey Findings on Diabetes Awareness Released by PatientAssistance.com
8. When the Caregiver Becomes the Patient
9. Caution Urged as Patients Seek Deals on Cosmetic Surgery
10. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card
11. New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...FirstCall/ -- PD-Rx Pharmaceuticals, Inc. (Pink Sh...for the first quarter ended September 30, 2009, a ...ating income and net income for the quarter were $...ease over the same period last year. ,, Results...les. This trend is expected to continue throughou...
(Date:12/4/2009)...The National Cancer Institute has awarded a $55.4 ... Cancer Research Center to become the nation,s sol...ct Center. ,, The move will create 60 new jobs ...e of its current CIS workforce - once the consolid...ed for March 15, 2010. The Seattle CIS center will...
(Date:12/4/2009)...e (BUSM) researchers at the Slone Epidemiology Cen...ry products have a reduced incidence of uterine le...ack Women,s Health Study, appears in the current i... Uterine fibroids are benign tumors of the uterus...k women than white women. They are the primary ind...
(Date:12/4/2009)...guage patient education leaflets support Joint Com...uage access in healthcare organizations. , ...009 -- Lexi-Comp, Inc., a provider of clinical inf...on materials for healthcare institutions, understa...een the health care professional and the patient w...
(Date:12/4/2009)... Author and Political Analyst Leslie Sanchez proud...Providence Hospital’s “Adopt-a-Family ... $5000 in cash and toy donations for the charity a...match the donation. Toys will be distributed to fa...tal. , Washington, DC (P...
Breaking Medicine News(10 mins):Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Researchers find increased dairy intake reduces risk of uterine fibroids in black women 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 3Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2
...vailable in German . , Elimination diets can ...he number of children who have eczema has risen o...condition, which is often associated with an aller...mptoms worse. However, in information published to...
...eo Dramatizes Message That Pulmonary Fibrosis Can ...ith CPF to Find a Cure , , SAN JOSE, Calif., Marc...13 minutes in the U.S., the same number of lives e...nary Fibrosis (CPF) today launched a new public se...
...nt of imaging techniques, the accuracy of preopera...lly, and the preservation of physical function in ... aim of research., A research article to be publ... cancer, and examines the therapeutic efficacy and...
...tine and Tobacco Research Analyzes Trends, Impact ...To date, the majority of research conducted about ...rate to heavy smoking. The March 2009 issue of N...earchers worked together to uncover trends related...
...eople might be dangerous for others, , , F...ve confirmed previously reported genetic factors t... proper dosage of the blood thinner warfarin to pe...lant medication to prevent blood clots and reduce ...
... 20 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the g...ed today a voluntary market withdrawal/recall of t...he lots of DAYTRANA patches affected by this actio...ult, patients and caregivers could have difficulti...
Other Medicine News:Health News:Eczema in children is increasing, but diet is not the cause 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 2Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 4Health News:Genetics Should Decide Warfarin Dose, Study Reiterates 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 3Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 4Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 5
(Date:12/4/2009)..., Opposes use of imported drugs often stored .... 4 Today, the senior a...t the Dorgan Importation plan encompassed in SA 27...ator Dorgan,s importation amendment is poised to o...stem to be breached, and our health to be endanger...
(Date:12/4/2009)... , HOUSTON, Dec. 4 /PRNewswire/ ...e AcceleDent System , which is an acceleration de...bility of a new Continuing Education course publis...ional education for many industries, including med...t views about orthodontic treatment, a summary of ...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 /PRNewswire-FirstCall/ ..."Company") (OTC Bulletin Board: NWBO) announced to...lowed its patent application on a system for autom...the Company,s DCVax® therapeutic cancer vacci...o the very high concentration of dendritic cells (...
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Curtain twitching skylarks keep track of strangers through their songs 9716 1Curtain twitching skylarks keep track of strangers through their songs 9716 2U Iowa improves delivery of cancer fighting molecules 9711 1U Iowa improves delivery of cancer fighting molecules 9711 2Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2
...as an Adjuvant and Play Key Role in the,Treatment ...20, 2007 /PRNewswire-FirstCall/ --,ImmuneRegen Bio...ces Holdings, Inc. , announced today that data obt...mspera, suggests that the,compound has potential v.... Studies performed in animal models of influenza ...
...20, 2007 -- Clinical studies have,shown (1) simila...diatric influenza patients being treated with Tami...heir influenza. Furthermore,recent data derived f...006 of over 101,000 influenza patients treated wit...taking Tamiflu have shown,that the Tamiflu treated...
Other Medicine Technology:ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 2ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 3ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 4New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
Discovery 90 Ultracentrifuges
...000M does everything you want a floor model centri...ating Power , PR-7000M delivers up to 50% more for...ations are done faster and more efficiently., Tr... 6 liters, PR-7000M accommodates 30 microplates, u...
RC 26 PLUS
RC12BP
Medicine Products: